Nine sessions now in the same neutral-to-down read, and today it stopped being a label and started showing up in the numbers. The Nifty is down for the ninth straight transition-regime day, closing at 23,398, and the internals are worse than the index suggests. Just 36% of stocks sit above their 20-day average, the lowest reading in this entire 30-session window. Fifty-two-week lows now outnumber highs by 42, also the weakest print in the window. This is not a one-day wobble, it is breadth grinding lower under a market that has already fallen roughly 1,376 points since early August.
The Stage-2 cohort is shrinking, and shrinking faster
The share of stocks in Stage 2 is down to 33%, having dropped 4.2 percentage points over the last 20 sessions, the steepest such decline anywhere in this window. Three weeks ago that share was still climbing. Transitions into Stage 2 have slowed to 25 in the last five sessions while transitions into Stage 3 (topping) have run at 56, a lopsided ratio that has been building since late August. Stocks sitting in Stage 4 have risen from 702 a couple of weeks back to 744 today. The stock-picking pool for this screen is quietly getting smaller.
Crosses have flipped
Death crosses hit 10 today against just 6 golden crosses, the highest death-cross count anywhere in the 30-session run. For most of August golden crosses were outnumbering death crosses comfortably; that relationship has now inverted. Combined with median setup scores still hovering around 6.1 even as breadth falls, the message is that a handful of names remain constructive while the broader tape deteriorates underneath them. That is a market for selectivity, not conviction.
Energy and sugar are the exceptions worth watching
Energy is the one sector with rising Stage-2 participation, up nearly 27 percentage points over 20 sessions to 52% of the sector, led by Oil & Gas Equipment & Services (75% in Stage 2, up 50 points) and Storage & Transportation, which actually closed up on a day almost everything else fell. Sugar is a smaller pocket doing something similar: 75% of the industry in Stage 2, up close to 40 points in three weeks. On the setup list, Oriental Aromatics, Fineotex Chemical and AVT Natural Products all carry scores near 9.8, and Ugar Sugar Works and Mawana Sugars show up among the pullback names. Worth watching, not worth chasing blind — the screen surfaces these every day regardless of the tape, and today's tape is not one to lean on.
| Stock | Sector | Setup | % 1D |
|---|---|---|---|
| Oriental Aromatics Ltd | Materials | 9.8 | — |
| Welspun Investments and Commercials Ltd | Financials | 9.8 | — |
| AVT Natural Products Ltd | Consumer Staples | 9.8 | — |
| Fineotex Chemical Ltd | Materials | 9.8 | — |
| Modison Ltd | Industrials | 9.6 | — |
| Omaxe Ltd | Real Estate | 9.6 | — |
| Raghav Productivity Enhancers Ltd | Materials | 9.6 | — |
| Bliss GVS Pharma Ltd | Health Care | 9.5 | — |
| Sector | 1D | 1M | 3M | RS | Stage 2 |
|---|---|---|---|---|---|
| Communication Services | +0.4% | -1.0% | +7.8% | 59 | 25% |
| Information Technology | +0.1% | -6.0% | +3.9% | 46 | 26% |
| Financials | -0.0% | -2.6% | -0.0% | 59 | 33% |
| Health Care | -0.3% | +0.7% | +11.2% | 71 | 47% |
| Consumer Staples | -0.3% | -5.8% | -4.2% | 44 | 35% |
| Consumer Discretionary | -0.4% | -2.2% | +8.4% | 59 | 34% |
| Industrials | -0.5% | -1.6% | +2.7% | 68 | 29% |
| Utilities | -0.9% | -3.2% | -6.6% | 57 | 16% |
| Energy | -1.1% | -3.1% | -1.6% | 57 | 52% |
| Materials | -1.4% | -1.5% | +1.2% | 63 | 36% |
| Real Estate | -2.2% | -4.0% | +5.9% | 53 | 27% |
Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.
Nifty +0.2% but internals keep deteriorating
Decliners beat advancers 1,554 to 918; net new highs just turned negative. This is not a dip inside strength.
Nifty -0.9%: tape hollowing out, not holding
Decliners beat advancers 1,576 to 908, net new highs collapsed to +8 — the bounce is over.
Nifty range-bound, internals still leaking — not a dip to trust
Decliners beat advancers again, Stage-2 cohort shrinking, and 70 stocks left Stage 2 in five days.